Anna Legreid Dopp

624 total citations
15 papers, 376 citations indexed

About

Anna Legreid Dopp is a scholar working on Public Health, Environmental and Occupational Health, Geriatrics and Gerontology and General Health Professions. According to data from OpenAlex, Anna Legreid Dopp has authored 15 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 5 papers in Geriatrics and Gerontology and 4 papers in General Health Professions. Recurrent topics in Anna Legreid Dopp's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Opioid Use Disorder Treatment (3 papers) and Pain Management and Opioid Use (2 papers). Anna Legreid Dopp is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Opioid Use Disorder Treatment (3 papers) and Pain Management and Opioid Use (2 papers). Anna Legreid Dopp collaborates with scholars based in United States. Anna Legreid Dopp's co-authors include Michael J. Rouse, Jay Kaplan, Lois Margaret Nora, Timothy P. Brigham, Cynthia D. Smith, James E. Tisdale, John M. Miller, Christine A. Sinsky, Aditi Mallick and Lorna A. Lynn and has published in prestigious journals such as Drugs, Journal of Occupational and Environmental Medicine and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Anna Legreid Dopp

15 papers receiving 357 citations

Peers

Countries citing papers authored by Anna Legreid Dopp

Since Specialization

Citations

This map shows the geographic impact of Anna Legreid Dopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Legreid Dopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Legreid Dopp more than expected).

Fields of papers citing papers by Anna Legreid Dopp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Legreid Dopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Legreid Dopp. The network helps show where Anna Legreid Dopp may publish in the future.

Co-authorship network of co-authors of Anna Legreid Dopp

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Legreid Dopp. A scholar is included among the top collaborators of Anna Legreid Dopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Legreid Dopp. Anna Legreid Dopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The State of Health, Burnout, Healthy Behaviors, Workplace Wellness Support, and Concerns of Medication Errors in Pharmacists During the COVID-19 Pandemic 2023 ·Journal of Occupational and Environmental Medicine ·Bernadette Mazurek Melnyk, Andreanna Pavan Hsieh, Alai Tan, James W. McAuley, (unknown), (unknown), Anna Legreid Dopp	9
2	Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy 2023 ·Substance Abuse ·Jennie B. Jarrett, Jeffrey Bratberg, Anne Burns, Gerald Cochran, Bethany A. DiPaula, Anna Legreid Dopp, (unknown), Traci C. Green, Lucas G. Hill, (unknown), (unknown), Michele L. Matthews, Udi E. Ghitza, Li‐Tzy Wu, Gavin Bart	8
3	Integrating Telehealth and Traditional Care in Chronic Pain Management and Substance Use Disorder Treatment: An Action Agenda for Building the Future State of Hybrid Care 2023 ·NAM Perspectives ·(unknown), Kelly James Clark, (unknown), (unknown), Anna Legreid Dopp, (unknown), Elizabeth Bentley, (unknown), (unknown), Friedhelm Sandbrink, (unknown), (unknown), (unknown), Shari M. Ling, Ellen Eaton, (unknown), (unknown)	2
4	Combatting the Stigma of Addiction—The Need for a Comprehensive Health System Approach 2020 ·NAM Perspectives ·Jennifer Atkins, Anna Legreid Dopp, (unknown)	13
5	Organizational Evidence-Based and Promising Practices for Improving Clinician Well-Being 2020 ·NAM Perspectives ·Christine A. Sinsky, (unknown), Aditi Mallick, Anna Legreid Dopp, (unknown), Lorna A. Lynn, Cynthia D. Smith	60
6	Improving patient care and demonstrating value during a global pandemic: Recommendations from leaders of the Pharmacy Accountability Measures Work Group 2020 ·American Journal of Health-System Pharmacy ·(unknown), Jannet M. Carmichael, Curtis D. Collins, Anna Legreid Dopp, (unknown), (unknown), (unknown)	5
7	Formalizing the profession’s commitment to preventing violence 2020 ·American Journal of Health-System Pharmacy ·Anna Legreid Dopp	2
8	Best Practices, Research Gaps, and Future Priorities to Support Tapering Patients on Long-Term Opioid Therapy for Chronic Non-Cancer Pain in Outpatient Settings 2020 ·NAM Perspectives ·Robert Rich, Roger Chou, Edward R. Mariano, Anna Legreid Dopp, (unknown), Helen Burstin	23
9	A Journey to Construct an All-Encompassing Conceptual Model of Factors Affecting Clinician Well-Being and Resilience 2018 ·NAM Perspectives ·Timothy P. Brigham, (unknown), Anna Legreid Dopp, (unknown), (unknown), Jay Kaplan, (unknown), (unknown), (unknown), (unknown), (unknown), Lois Margaret Nora	128
10	Medication oversupply in patients with diabetes 2014 ·Research in Social and Administrative Pharmacy ·Carolyn T. Thorpe, Heather M. Johnson, Anna Legreid Dopp, Joshua M. Thorpe, (unknown), Christine Everett, Mari Palta, David A. Mott, Betty Chewning, Loren J. Schleiden, Maureen A. Smith	10
11	Pharmacy Students' Retention of Knowledge and Skills Following Training in Automated External Defibrillator Use 2010 ·American Journal of Pharmaceutical Education ·(unknown), Anna Legreid Dopp, John M. Dopp, Orly Vardeny, Jason Sims	19
12	A Five-State Continuing Professional Development Pilot Program for Practicing Pharmacists 2010 ·American Journal of Pharmaceutical Education ·Anna Legreid Dopp, (unknown), Michael J. Rouse, (unknown)	68
13	Key Articles and Guidelines in the Management of Arrhythmias, 2004–2010 2010 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Judy W.M. Cheng, Anna Legreid Dopp, James S. Kalus, Kelly C. Rogers, Cynthia A. Sanoski, C Michael White	2
14	Report of the 2008–2009 Standing Committee on Advocacy 2009 ·American Journal of Pharmaceutical Education ·James P. Kehrer, Gayle A. Brazeau, (unknown), Anna Legreid Dopp, (unknown), (unknown), William Lang	1
15	Effect of Drugs on Defibrillation Capacity 2008 ·Drugs ·Anna Legreid Dopp, John M. Miller, James E. Tisdale	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact